{"id":"https://openalex.org/W4416103138","doi":"https://doi.org/10.1136/thorax-2025-btsabstracts.273","title":"P91 Real-world healthcare resource utilization in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy in the medicare fee-for-service population","display_name":"P91 Real-world healthcare resource utilization in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy in the medicare fee-for-service population","publication_year":2025,"publication_date":"2025-11-01","ids":{"openalex":"https://openalex.org/W4416103138","doi":"https://doi.org/10.1136/thorax-2025-btsabstracts.273"},"language":"en","primary_location":{"id":"doi:10.1136/thorax-2025-btsabstracts.273","doi":"https://doi.org/10.1136/thorax-2025-btsabstracts.273","is_oa":false,"landing_page_url":"https://doi.org/10.1136/thorax-2025-btsabstracts.273","pdf_url":null,"source":{"id":"https://openalex.org/S106546978","display_name":"Thorax","issn_l":"0040-6376","issn":["0040-6376","1468-3296"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Insights and advances in ILD care","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080688853","display_name":"B Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Wu","raw_affiliation_strings":["United Therapeutics Corporation, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United Therapeutics Corporation, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Yu","raw_affiliation_strings":["Inovalon, Bowie, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovalon, Bowie, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"M Lin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Lin","raw_affiliation_strings":["United Therapeutics Corporation, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United Therapeutics Corporation, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071086365","display_name":"Erin Roberts","orcid":"https://orcid.org/0000-0002-9169-9456","observed_orcids":["https://orcid.org/0000-0002-9169-9456"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Roberts-McCarthy","raw_affiliation_strings":["Inovalon, Bowie, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovalon, Bowie, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043656516","display_name":"Kellie Morland","orcid":"https://orcid.org/0000-0003-1800-7983","observed_orcids":["https://orcid.org/0000-0003-1800-7983"]},"institutions":[{"id":"https://openalex.org/I4210136935","display_name":"United Therapeutics (United States)","ror":"https://ror.org/03wgxjb31","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136935"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K Morland","raw_affiliation_strings":["United Therapeutics Corporation, Research Triangle Park, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"United Therapeutics Corporation, Research Triangle Park, USA","institution_ids":["https://openalex.org/I4210136935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051164034","display_name":"Scott B. Robinson","orcid":"https://orcid.org/0000-0001-6661-5284","observed_orcids":["https://orcid.org/0000-0001-6661-5284","https://orcid.org/0000-0001-8167-1030"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Robinson","raw_affiliation_strings":["Inovalon, Bowie, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inovalon, Bowie, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079543303","display_name":"Murali Ramaswamy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324118502","display_name":"Moses H Cone Memorial Hospital","ror":"https://ror.org/045m9y072","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313334418","https://openalex.org/I1324118502"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M Ramaswamy","raw_affiliation_strings":["Moses H. Cone Memorial Hospital, Greensboro, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moses H. Cone Memorial Hospital, Greensboro, USA","institution_ids":["https://openalex.org/I1324118502"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A190.2","last_page":"A190"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11189","display_name":"Transplantation: Methods and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/idiopathic-pulmonary-fibrosis","display_name":"idiopathic pulmonary fibrosis","score":1.0},{"id":"https://openalex.org/keywords/antifibrotic-therapy","display_name":"antifibrotic therapy","score":0.9959999918937683},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7879999876022339},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9570000171661377},{"id":"https://openalex.org/keywords/fee-for-service-medicare","display_name":"fee-for-service Medicare","score":0.8859999775886536},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.777999997138977},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.9629999995231628},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.5450000166893005},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7390000224113464},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.7059999704360962},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.7170000076293945},{"id":"https://openalex.org/keywords/lung-transplantation","display_name":"lung transplantation","score":0.3840000033378601},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6340000033378601},{"id":"https://openalex.org/keywords/end-of-life-care","display_name":"end-of-life care","score":0.3930000066757202},{"id":"https://openalex.org/keywords/palliative-care","display_name":"palliative care","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9715999960899353},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.817799985408783},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5748999714851379},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5217999815940857},{"id":"https://openalex.org/C3019063607","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Charlson comorbidity index","level":3,"score":0.4706000089645386},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.46540001034736633},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.45399999618530273},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.42579999566078186},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.42570000886917114},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.41780000925064087},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.4004000127315521},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3716999888420105},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.3319999873638153},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.32260000705718994},{"id":"https://openalex.org/C2775909303","wikidata":"https://www.wikidata.org/wiki/Q3259564","display_name":"Inpatient care","level":3,"score":0.31029999256134033},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.30309998989105225},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.29019999504089355},{"id":"https://openalex.org/C179755657","wikidata":"https://www.wikidata.org/wiki/Q58702","display_name":"Mortality rate","level":2,"score":0.2705000042915344},{"id":"https://openalex.org/C61470247","wikidata":"https://www.wikidata.org/wiki/Q7229825","display_name":"Population study","level":3,"score":0.2680000066757202},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.267300009727478},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.2590999901294708},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.2531999945640564},{"id":"https://openalex.org/C2778829437","wikidata":"https://www.wikidata.org/wiki/Q6806632","display_name":"Medicare Advantage","level":3,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/thorax-2025-btsabstracts.273","doi":"https://doi.org/10.1136/thorax-2025-btsabstracts.273","is_oa":false,"landing_page_url":"https://doi.org/10.1136/thorax-2025-btsabstracts.273","pdf_url":null,"source":{"id":"https://openalex.org/S106546978","display_name":"Thorax","issn_l":"0040-6376","issn":["0040-6376","1468-3296"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Insights and advances in ILD care","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412443196","https://openalex.org/W4404046106","https://openalex.org/W2981198993","https://openalex.org/W2980535026","https://openalex.org/W3216734327","https://openalex.org/W4403518750","https://openalex.org/W3092954321","https://openalex.org/W4410270282","https://openalex.org/W4387219365","https://openalex.org/W7161554409"],"abstract_inverted_index":{"Objectives":[0],"To":[1],"characterize":[2],"treatment":[3,259],"patterns":[4],"and":[5,43,65,86,156,175,197,204,233,265],"healthcare":[6,83],"resource":[7,84],"utilization":[8,85],"in":[9,188,193,272],"patients":[10,33,46,129,168,200,234,273],"with":[11,125,150,255,274],"idiopathic":[12,275],"pulmonary":[13,276],"fibrosis":[14],"initiating":[15,134,138],"antifibrotic":[16,36,69,170,262],"therapy.":[17],"Methods":[18],"A":[19,267],"retrospective":[20],"cohort":[21],"study":[22],"was":[23,115,148],"conducted":[24],"using":[25,75,117],"the":[26,94,100,189,194],"100%":[27],"Medicare":[28],"Fee-For-Service":[29],"data":[30],"to":[31,99,191,218,226,240,248,261],"identify":[32],"who":[34],"initiated":[35],"therapy":[37,70,171,224],"(nintendanib":[38],"or":[39,53,71,109],"pirfenidone)":[40],"between":[41],"01/01/17":[42],"12/31/22.":[44],"Eligible":[45],"were":[47,88,91,212,215,245],"aged":[48,213,228],"\u226518,":[49],"had":[50,66],"\u22651":[51],"inpatient":[52,183],"\u22652":[54],"outpatient":[55],"IPF":[56,256],"diagnosis":[57],"claims":[58],"pre-index,":[59],"continuously":[60],"enrolled":[61],"for":[62],"6-months":[63],"prior":[64,68,239],"no":[67],"lung":[72,103],"transplant.":[73],"Discontinuation,":[74],"a":[76,237],"45-day":[77],"gap":[78],"definition,":[79],"per-person":[80],"per-month":[81],"(PPPM)":[82],"mortality":[87],"examined.":[89],"Patients":[90,210,254],"censored":[92],"at":[93,146,172,177,202],"earliest":[95],"occurrence":[96],"of":[97,107,111,164,167,199],"switching":[98],"other":[101],"antifibrotic,":[102],"transplant,":[104],"death,":[105],"end":[106,110],"enrollment,":[108],"data.":[112],"Unadjusted":[113],"time-to-event":[114],"estimated":[116],"Kaplan-Meier":[118],"Cox-proportional":[119],"hazards":[120],"model":[121],"identified":[122],"characteristics":[123],"associated":[124],"discontinuation.":[126],"Results":[127],"5,397":[128],"met":[130],"selection":[131],"criteria,":[132],"3,555":[133],"nintendanib":[135],"and/or":[136],"2,496":[137],"pirfenidone.":[139],"For":[140],"all":[141],"patients,":[142],"mean":[143,157],"(SD)":[144,158,181],"age":[145],"initiation":[147,241],"75.6(7.3),":[149],"38%":[151],"female,":[152],"87%":[153],"white":[154],"race":[155],"Deyo":[159],"Charlson":[160],"comorbidity":[161],"index":[162],"score":[163],"2.6(2.4).":[165],"25%":[166,196],"discontinued":[169],"3":[173],"months":[174,206],"50%":[176,198],"11":[178],"months.":[179],"Mean":[180],"PPPM":[182],"hospitalizations":[184,264],"increased":[185],"from":[186],"0.07(0.13)":[187],"pre-index":[190],"0.10(0.26)":[192],"post-index.":[195],"died":[201],"18":[203],"41":[205],"after":[207,251],"initiation,":[208],"respectively.":[209],"that":[211,235],"\u226575":[214],"more":[216],"likely":[217,247],"discontinue":[219,249],"(HR":[220],"1.23;":[221],"95%CI:":[222,243],"1.14\u20131.33)":[223],"relative":[225],"those":[227],"<75.":[229],"Men":[230],"(HR:0.76;":[231],"95%CI:0.71\u20130.81)":[232],"experienced":[236],"hospitalization":[238],"(HR:0.85;":[242],"0.78\u20130.94)":[244],"less":[246],"therapy,":[250,263],"adjustment.":[252],"Conclusions":[253],"have":[257],"high":[258],"discontinuation":[260],"mortality.":[266],"large":[268],"unmet":[269],"need":[270],"remains":[271],"fibrosis.":[277]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2025-11-11T00:00:00"}